ESC 365 - Contamination rate in the risk or benefit in screening for cardiovascular disease (ROBINSCA)-trial

EAPC Premium Access

Contamination rate in the risk or benefit in screening for cardiovascular disease (ROBINSCA)-trial

Session: Poster Session 1 - Risk Factors and Prevention – Cardiovascular Risk Assessment

Topic: Cardiovascular Risk Assessment

Speaker: Ms S. Denissen (Rotterdam, NL)

Event: EuroPrevent 2018

Congress Presentation

Add to my library

About the speaker

Ms Sabine Denissen

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

0 follower

10 more presentations in this session

Risk Factors and Prevention – Cardiovascular Risk Assessment - Poster discussant:

The stratification of cardiovascular risk in rheumatoid arthritis

Smoking cessation program:marked risk reduction of coronary heart disease in pre-graduate individuals.

Speaker: Professor N. Sen (Jaipur, IN)

Exercise induced ST depression in a population with low risk for ischemic heart disease - prevalence and characteristics

Speaker: Doctor A. Carlen (Linkoping, SE)

Orthostatic test in prognosis of arterial hypertension in young adults

Speaker: Associate Professor O. Sklyanna (Donetsk, UA)

Access the full session

Poster Session 1 - Risk Factors and Prevention – Cardiovascular Risk Assessment

Speakers: Ms S. Denissen, Professor N. Sen, Doctor A. Carlen, Associate Professor O. Sklyanna

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources